Scientific Program

Conference Series Ltd invites all the participants across the globe to attend Pharmaceutical Summit and Expo New Delhi, India.

Day :

Biography:

Nasimul Hoda has completed his PhD from Patna University and Postdoctoral studies from IIT Delhi, Supercomputing facility for bioinformatics and computational biology (SCFBIO-IITD). He is the Assistant Professor in Chemistry at Jamia Millia Islamia (Central University). He is working in the field of Drug design and focussing on the development of antimalarial and anti-neurodegenerative agents.

Abstract:

Malaria is a leading cause of human deaths affected by parasitic infection in tropical and subtropical reasons. Out of the fourrnplasmodium species responsible for this disease in human Plasmodium falciparum is the most deadly. Due to the widespreadrnresistance of the current antimalarial drugs, intense research efforts are focused on identification of new potent antimalarials.rnWe report here, a structure based drug discovery strategy for design and synthesis of a series of potent and novel triazine basedrnantimalarials. The X-ray structure of Plasmodium falciparum phosphoethanolamine methyltransferase (PfPMT) is used as a target asrnit is unique to the parasite. Trisubstituted triazine and its anlaogs are produced by an inexpensive three to four step synthesis givingrnexcellent yields. Parasite growth inhibition assays further confirmed the activity of the molecules to be in 5 to 0.8 μM range showingrnselectivity towards the parasite over mammalian cells. Molecular dynamics simulations on the PfPMT-inhibitor complex shed lightrnon the inhibition mechanism for further optimization of the lead compounds.